An Overview on Pathways & Outcomes of Wet AMD & Diabetic Retinopathy
Time: 9:00 am
day: Day One
Details:
- Exploring molecular pathways contributing to diabetic retinopathy and wet AMD to understand variations in treatment efficacy
- Identifying key biomarkers that guide the selection of effective therapies and support combination approaches
- Addressing unmet needs by informing drug development with insights on patients who are unresponsive to current treatments
